ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Cotton Spunlaced Non-woven Fabric Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-9L17885
Home | Market Reports | Business & Industrial| Textiles & Nonwovens
Global Medical Cotton Spunlaced Non woven Fabric Market Research Report 2024
BUY CHAPTERS

Global Medical Cotton Spunlaced Non-woven Fabric Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-9L17885
Report
October 2025
Pages:187
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Winner
Jacob Holm (Glatfelter)
Unitika
Hubei Xinrou Sanitary Products
Anhui Huamao Group
Textisol
Spuntech
Ihsan Sons
Welspun
Fujian Funeng
Xinlong
Salvin Textile
JiaXin Medical
Texhong
Sanitars
Eruslu Nonwoven Group (ENG)
Orma Spunlace
Rusvata
MOGUL
Napal
WPT Nonwovens
Taebong
Daesung Medical

Medical Cotton Spunlaced Non-woven Fabric Market

The global Medical Cotton Spunlaced Non-woven Fabric market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Medical cotton spunlace non-woven fabric is a non-woven material used for medical purposes. It is made by spunlace method and has the following characteristics: Material pure cotton: Medical cotton spunlace non-woven fabric uses pure cotton fiber Made of soft, breathable and highly absorbent features that are beneficial to patient comfort and skin health. Non-woven fabric production: Made through the spunlace process, the non-woven fabric is more uniform, softer and has a certain strength. It is suitable for use in medical dressings, surgical gowns, masks, medical sanitary napkins and other products. Medical needs: Medical cotton spunlace non-woven fabrics usually comply with the relevant standards and requirements of medical devices and can be used in the manufacture of products that directly contact the patient's skin. Medical cotton spunlace non-woven fabrics are widely used in the medical and health field, and are often used in the manufacture of medical and health products to provide comfortable and safe medical protection.
From a downstream perspective, Surgical Gown accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Medical Cotton Spunlaced Non-woven Fabric leading manufacturers including WINNER, Jacob Holm (Glatfelter), Unitika, Hubei Xinrou Sanitary Products, ANHUI HUAMAO GROUP, Textisol, Spuntech, Ihsan Sons, Welspun, Fujian Funeng, etc., dominate supply; the top five capture approximately % of global revenue, with WINNER leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Medical Cotton Spunlaced Non-woven Fabric market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Medical Cotton Spunlaced Non-woven Fabric Market Report

Report Metric Details
Report Name Medical Cotton Spunlaced Non-woven Fabric Market
Segment by Type
  • Below 40gsm
  • 40-70gsm
  • 70gsm and Above
Segment by Application
  • Surgical Gown
  • Protective Suit
  • Medical Masks
  • Medical Gauze
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company WINNER, Jacob Holm (Glatfelter), Unitika, Hubei Xinrou Sanitary Products, ANHUI HUAMAO GROUP, Textisol, Spuntech, Ihsan Sons, Welspun, Fujian Funeng, XINLONG, Salvin Textile, JIAXIN MEDICAL, TEXHONG, Sanitars, Eruslu Nonwoven Group (ENG), Orma Spunlace, Rusvata, MOGUL, Napal, WPT Nonwovens, Taebong, Daesung Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Medical Cotton Spunlaced Non-woven Fabric study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Medical Cotton Spunlaced Non-woven Fabric Market report?

Ans: The main players in the Medical Cotton Spunlaced Non-woven Fabric Market are WINNER, Jacob Holm (Glatfelter), Unitika, Hubei Xinrou Sanitary Products, ANHUI HUAMAO GROUP, Textisol, Spuntech, Ihsan Sons, Welspun, Fujian Funeng, XINLONG, Salvin Textile, JIAXIN MEDICAL, TEXHONG, Sanitars, Eruslu Nonwoven Group (ENG), Orma Spunlace, Rusvata, MOGUL, Napal, WPT Nonwovens, Taebong, Daesung Medical

What are the Application segmentation covered in the Medical Cotton Spunlaced Non-woven Fabric Market report?

Ans: The Applications covered in the Medical Cotton Spunlaced Non-woven Fabric Market report are Surgical Gown, Protective Suit, Medical Masks, Medical Gauze, Others

What are the Type segmentation covered in the Medical Cotton Spunlaced Non-woven Fabric Market report?

Ans: The Types covered in the Medical Cotton Spunlaced Non-woven Fabric Market report are Below 40gsm, 40-70gsm, 70gsm and Above

1 Study Coverage
1.1 Introduction to Medical Cotton Spunlaced Non-woven Fabric: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medical Cotton Spunlaced Non-woven Fabric Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Below 40gsm
1.2.3 40-70gsm
1.2.4 70gsm and Above
1.3 Market Segmentation by Application
1.3.1 Global Medical Cotton Spunlaced Non-woven Fabric Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Surgical Gown
1.3.3 Protective Suit
1.3.4 Medical Masks
1.3.5 Medical Gauze
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Cotton Spunlaced Non-woven Fabric Revenue Estimates and Forecasts 2020-2031
2.2 Global Medical Cotton Spunlaced Non-woven Fabric Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Medical Cotton Spunlaced Non-woven Fabric Sales Estimates and Forecasts 2020-2031
2.4 Global Medical Cotton Spunlaced Non-woven Fabric Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Medical Cotton Spunlaced Non-woven Fabric Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Medical Cotton Spunlaced Non-woven Fabric Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Medical Cotton Spunlaced Non-woven Fabric Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Below 40gsm Market Size by Manufacturers
4.5.2 40-70gsm Market Size by Manufacturers
4.5.3 70gsm and Above Market Size by Manufacturers
4.6 Global Medical Cotton Spunlaced Non-woven Fabric Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Medical Cotton Spunlaced Non-woven Fabric Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Medical Cotton Spunlaced Non-woven Fabric Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Medical Cotton Spunlaced Non-woven Fabric Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Medical Cotton Spunlaced Non-woven Fabric Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Medical Cotton Spunlaced Non-woven Fabric Sales and Revenue by Type (2020-2031)
7.4 North America Medical Cotton Spunlaced Non-woven Fabric Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Medical Cotton Spunlaced Non-woven Fabric Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Medical Cotton Spunlaced Non-woven Fabric Sales and Revenue by Type (2020-2031)
8.4 Europe Medical Cotton Spunlaced Non-woven Fabric Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Medical Cotton Spunlaced Non-woven Fabric Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Medical Cotton Spunlaced Non-woven Fabric Sales and Revenue by Type (2020-2031)
10.4 Central and South America Medical Cotton Spunlaced Non-woven Fabric Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Medical Cotton Spunlaced Non-woven Fabric Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Medical Cotton Spunlaced Non-woven Fabric Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Medical Cotton Spunlaced Non-woven Fabric Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Medical Cotton Spunlaced Non-woven Fabric Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 WINNER
12.1.1 WINNER Corporation Information
12.1.2 WINNER Business Overview
12.1.3 WINNER Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.1.4 WINNER Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 WINNER Medical Cotton Spunlaced Non-woven Fabric Sales by Product in 2024
12.1.6 WINNER Medical Cotton Spunlaced Non-woven Fabric Sales by Application in 2024
12.1.7 WINNER Medical Cotton Spunlaced Non-woven Fabric Sales by Geographic Area in 2024
12.1.8 WINNER Medical Cotton Spunlaced Non-woven Fabric SWOT Analysis
12.1.9 WINNER Recent Developments
12.2 Jacob Holm (Glatfelter)
12.2.1 Jacob Holm (Glatfelter) Corporation Information
12.2.2 Jacob Holm (Glatfelter) Business Overview
12.2.3 Jacob Holm (Glatfelter) Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.2.4 Jacob Holm (Glatfelter) Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Jacob Holm (Glatfelter) Medical Cotton Spunlaced Non-woven Fabric Sales by Product in 2024
12.2.6 Jacob Holm (Glatfelter) Medical Cotton Spunlaced Non-woven Fabric Sales by Application in 2024
12.2.7 Jacob Holm (Glatfelter) Medical Cotton Spunlaced Non-woven Fabric Sales by Geographic Area in 2024
12.2.8 Jacob Holm (Glatfelter) Medical Cotton Spunlaced Non-woven Fabric SWOT Analysis
12.2.9 Jacob Holm (Glatfelter) Recent Developments
12.3 Unitika
12.3.1 Unitika Corporation Information
12.3.2 Unitika Business Overview
12.3.3 Unitika Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.3.4 Unitika Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Unitika Medical Cotton Spunlaced Non-woven Fabric Sales by Product in 2024
12.3.6 Unitika Medical Cotton Spunlaced Non-woven Fabric Sales by Application in 2024
12.3.7 Unitika Medical Cotton Spunlaced Non-woven Fabric Sales by Geographic Area in 2024
12.3.8 Unitika Medical Cotton Spunlaced Non-woven Fabric SWOT Analysis
12.3.9 Unitika Recent Developments
12.4 Hubei Xinrou Sanitary Products
12.4.1 Hubei Xinrou Sanitary Products Corporation Information
12.4.2 Hubei Xinrou Sanitary Products Business Overview
12.4.3 Hubei Xinrou Sanitary Products Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.4.4 Hubei Xinrou Sanitary Products Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Hubei Xinrou Sanitary Products Medical Cotton Spunlaced Non-woven Fabric Sales by Product in 2024
12.4.6 Hubei Xinrou Sanitary Products Medical Cotton Spunlaced Non-woven Fabric Sales by Application in 2024
12.4.7 Hubei Xinrou Sanitary Products Medical Cotton Spunlaced Non-woven Fabric Sales by Geographic Area in 2024
12.4.8 Hubei Xinrou Sanitary Products Medical Cotton Spunlaced Non-woven Fabric SWOT Analysis
12.4.9 Hubei Xinrou Sanitary Products Recent Developments
12.5 ANHUI HUAMAO GROUP
12.5.1 ANHUI HUAMAO GROUP Corporation Information
12.5.2 ANHUI HUAMAO GROUP Business Overview
12.5.3 ANHUI HUAMAO GROUP Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.5.4 ANHUI HUAMAO GROUP Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 ANHUI HUAMAO GROUP Medical Cotton Spunlaced Non-woven Fabric Sales by Product in 2024
12.5.6 ANHUI HUAMAO GROUP Medical Cotton Spunlaced Non-woven Fabric Sales by Application in 2024
12.5.7 ANHUI HUAMAO GROUP Medical Cotton Spunlaced Non-woven Fabric Sales by Geographic Area in 2024
12.5.8 ANHUI HUAMAO GROUP Medical Cotton Spunlaced Non-woven Fabric SWOT Analysis
12.5.9 ANHUI HUAMAO GROUP Recent Developments
12.6 Textisol
12.6.1 Textisol Corporation Information
12.6.2 Textisol Business Overview
12.6.3 Textisol Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.6.4 Textisol Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Textisol Recent Developments
12.7 Spuntech
12.7.1 Spuntech Corporation Information
12.7.2 Spuntech Business Overview
12.7.3 Spuntech Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.7.4 Spuntech Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Spuntech Recent Developments
12.8 Ihsan Sons
12.8.1 Ihsan Sons Corporation Information
12.8.2 Ihsan Sons Business Overview
12.8.3 Ihsan Sons Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.8.4 Ihsan Sons Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Ihsan Sons Recent Developments
12.9 Welspun
12.9.1 Welspun Corporation Information
12.9.2 Welspun Business Overview
12.9.3 Welspun Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.9.4 Welspun Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Welspun Recent Developments
12.10 Fujian Funeng
12.10.1 Fujian Funeng Corporation Information
12.10.2 Fujian Funeng Business Overview
12.10.3 Fujian Funeng Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.10.4 Fujian Funeng Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Fujian Funeng Recent Developments
12.11 XINLONG
12.11.1 XINLONG Corporation Information
12.11.2 XINLONG Business Overview
12.11.3 XINLONG Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.11.4 XINLONG Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 XINLONG Recent Developments
12.12 Salvin Textile
12.12.1 Salvin Textile Corporation Information
12.12.2 Salvin Textile Business Overview
12.12.3 Salvin Textile Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.12.4 Salvin Textile Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Salvin Textile Recent Developments
12.13 JIAXIN MEDICAL
12.13.1 JIAXIN MEDICAL Corporation Information
12.13.2 JIAXIN MEDICAL Business Overview
12.13.3 JIAXIN MEDICAL Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.13.4 JIAXIN MEDICAL Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 JIAXIN MEDICAL Recent Developments
12.14 TEXHONG
12.14.1 TEXHONG Corporation Information
12.14.2 TEXHONG Business Overview
12.14.3 TEXHONG Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.14.4 TEXHONG Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 TEXHONG Recent Developments
12.15 Sanitars
12.15.1 Sanitars Corporation Information
12.15.2 Sanitars Business Overview
12.15.3 Sanitars Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.15.4 Sanitars Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 Sanitars Recent Developments
12.16 Eruslu Nonwoven Group (ENG)
12.16.1 Eruslu Nonwoven Group (ENG) Corporation Information
12.16.2 Eruslu Nonwoven Group (ENG) Business Overview
12.16.3 Eruslu Nonwoven Group (ENG) Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.16.4 Eruslu Nonwoven Group (ENG) Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 Eruslu Nonwoven Group (ENG) Recent Developments
12.17 Orma Spunlace
12.17.1 Orma Spunlace Corporation Information
12.17.2 Orma Spunlace Business Overview
12.17.3 Orma Spunlace Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.17.4 Orma Spunlace Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.17.5 Orma Spunlace Recent Developments
12.18 Rusvata
12.18.1 Rusvata Corporation Information
12.18.2 Rusvata Business Overview
12.18.3 Rusvata Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.18.4 Rusvata Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.18.5 Rusvata Recent Developments
12.19 MOGUL
12.19.1 MOGUL Corporation Information
12.19.2 MOGUL Business Overview
12.19.3 MOGUL Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.19.4 MOGUL Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.19.5 MOGUL Recent Developments
12.20 Napal
12.20.1 Napal Corporation Information
12.20.2 Napal Business Overview
12.20.3 Napal Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.20.4 Napal Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.20.5 Napal Recent Developments
12.21 WPT Nonwovens
12.21.1 WPT Nonwovens Corporation Information
12.21.2 WPT Nonwovens Business Overview
12.21.3 WPT Nonwovens Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.21.4 WPT Nonwovens Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.21.5 WPT Nonwovens Recent Developments
12.22 Taebong
12.22.1 Taebong Corporation Information
12.22.2 Taebong Business Overview
12.22.3 Taebong Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.22.4 Taebong Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.22.5 Taebong Recent Developments
12.23 Daesung Medical
12.23.1 Daesung Medical Corporation Information
12.23.2 Daesung Medical Business Overview
12.23.3 Daesung Medical Medical Cotton Spunlaced Non-woven Fabric Product Models, Descriptions and Specifications
12.23.4 Daesung Medical Medical Cotton Spunlaced Non-woven Fabric Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.23.5 Daesung Medical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Medical Cotton Spunlaced Non-woven Fabric Industry Chain
13.2 Medical Cotton Spunlaced Non-woven Fabric Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Medical Cotton Spunlaced Non-woven Fabric Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Medical Cotton Spunlaced Non-woven Fabric Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Medical Cotton Spunlaced Non-woven Fabric Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Medical Cotton Spunlaced Non-woven Fabric Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Winner
Jacob Holm (Glatfelter)
Unitika
Hubei Xinrou Sanitary Products
Anhui Huamao Group
Textisol
Spuntech
Ihsan Sons
Welspun
Fujian Funeng
Xinlong
Salvin Textile
JiaXin Medical
Texhong
Sanitars
Eruslu Nonwoven Group (ENG)
Orma Spunlace
Rusvata
MOGUL
Napal
WPT Nonwovens
Taebong
Daesung Medical
List of Tables
 Table 1. Global Medical Cotton Spunlaced Non-woven Fabric Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Medical Cotton Spunlaced Non-woven Fabric Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Medical Cotton Spunlaced Non-woven Fabric Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Medical Cotton Spunlaced Non-woven Fabric Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Medical Cotton Spunlaced Non-woven Fabric Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Medical Cotton Spunlaced Non-woven Fabric Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Medical Cotton Spunlaced Non-woven Fabric Sales by Region (2020-2025) & (Tons)
 Table 8. Global Medical Cotton Spunlaced Non-woven Fabric Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Medical Cotton Spunlaced Non-woven Fabric Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Medical Cotton Spunlaced Non-woven Fabric Production by Region (2020-2025) & (Tons)
 Table 12. Global Medical Cotton Spunlaced Non-woven Fabric Production by Region (2026-2031) & (Tons)
 Table 13. Global Medical Cotton Spunlaced Non-woven Fabric Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Medical Cotton Spunlaced Non-woven Fabric Sales Share by Manufacturers (2020-2025)
 Table 15. Global Medical Cotton Spunlaced Non-woven Fabric Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Medical Cotton Spunlaced Non-woven Fabric Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Medical Cotton Spunlaced Non-woven Fabric by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Cotton Spunlaced Non-woven Fabric as of 2024)
 Table 19. Global Medical Cotton Spunlaced Non-woven Fabric Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Medical Cotton Spunlaced Non-woven Fabric Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Medical Cotton Spunlaced Non-woven Fabric Manufacturing Base and Headquarters
 Table 22. Global Medical Cotton Spunlaced Non-woven Fabric Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Medical Cotton Spunlaced Non-woven Fabric Sales by Type (2020-2025) & (Tons)
 Table 26. Global Medical Cotton Spunlaced Non-woven Fabric Sales by Type (2026-2031) & (Tons)
 Table 27. Global Medical Cotton Spunlaced Non-woven Fabric Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Medical Cotton Spunlaced Non-woven Fabric Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Medical Cotton Spunlaced Non-woven Fabric ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Medical Cotton Spunlaced Non-woven Fabric Sales by Application (2020-2025) & (Tons)
 Table 32. Global Medical Cotton Spunlaced Non-woven Fabric Sales by Application (2026-2031) & (Tons)
 Table 33. Medical Cotton Spunlaced Non-woven Fabric High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Medical Cotton Spunlaced Non-woven Fabric Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Medical Cotton Spunlaced Non-woven Fabric Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Medical Cotton Spunlaced Non-woven Fabric ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Medical Cotton Spunlaced Non-woven Fabric Growth Accelerators and Market Barriers
 Table 40. North America Medical Cotton Spunlaced Non-woven Fabric Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Medical Cotton Spunlaced Non-woven Fabric Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Medical Cotton Spunlaced Non-woven Fabric Growth Accelerators and Market Barriers
 Table 43. Europe Medical Cotton Spunlaced Non-woven Fabric Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Medical Cotton Spunlaced Non-woven Fabric Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Medical Cotton Spunlaced Non-woven Fabric Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Medical Cotton Spunlaced Non-woven Fabric Investment Opportunities and Key Challenges
 Table 50. Central and South America Medical Cotton Spunlaced Non-woven Fabric Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Medical Cotton Spunlaced Non-woven Fabric Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Medical Cotton Spunlaced Non-woven Fabric Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. WINNER Corporation Information
 Table 54. WINNER Description and Major Businesses
 Table 55. WINNER Product Models, Descriptions and Specifications
 Table 56. WINNER Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. WINNER Sales Value Proportion by Product in 2024
 Table 58. WINNER Sales Value Proportion by Application in 2024
 Table 59. WINNER Sales Value Proportion by Geographic Area in 2024
 Table 60. WINNER Medical Cotton Spunlaced Non-woven Fabric SWOT Analysis
 Table 61. WINNER Recent Developments
 Table 62. Jacob Holm (Glatfelter) Corporation Information
 Table 63. Jacob Holm (Glatfelter) Description and Major Businesses
 Table 64. Jacob Holm (Glatfelter) Product Models, Descriptions and Specifications
 Table 65. Jacob Holm (Glatfelter) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Jacob Holm (Glatfelter) Sales Value Proportion by Product in 2024
 Table 67. Jacob Holm (Glatfelter) Sales Value Proportion by Application in 2024
 Table 68. Jacob Holm (Glatfelter) Sales Value Proportion by Geographic Area in 2024
 Table 69. Jacob Holm (Glatfelter) Medical Cotton Spunlaced Non-woven Fabric SWOT Analysis
 Table 70. Jacob Holm (Glatfelter) Recent Developments
 Table 71. Unitika Corporation Information
 Table 72. Unitika Description and Major Businesses
 Table 73. Unitika Product Models, Descriptions and Specifications
 Table 74. Unitika Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Unitika Sales Value Proportion by Product in 2024
 Table 76. Unitika Sales Value Proportion by Application in 2024
 Table 77. Unitika Sales Value Proportion by Geographic Area in 2024
 Table 78. Unitika Medical Cotton Spunlaced Non-woven Fabric SWOT Analysis
 Table 79. Unitika Recent Developments
 Table 80. Hubei Xinrou Sanitary Products Corporation Information
 Table 81. Hubei Xinrou Sanitary Products Description and Major Businesses
 Table 82. Hubei Xinrou Sanitary Products Product Models, Descriptions and Specifications
 Table 83. Hubei Xinrou Sanitary Products Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Hubei Xinrou Sanitary Products Sales Value Proportion by Product in 2024
 Table 85. Hubei Xinrou Sanitary Products Sales Value Proportion by Application in 2024
 Table 86. Hubei Xinrou Sanitary Products Sales Value Proportion by Geographic Area in 2024
 Table 87. Hubei Xinrou Sanitary Products Medical Cotton Spunlaced Non-woven Fabric SWOT Analysis
 Table 88. Hubei Xinrou Sanitary Products Recent Developments
 Table 89. ANHUI HUAMAO GROUP Corporation Information
 Table 90. ANHUI HUAMAO GROUP Description and Major Businesses
 Table 91. ANHUI HUAMAO GROUP Product Models, Descriptions and Specifications
 Table 92. ANHUI HUAMAO GROUP Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. ANHUI HUAMAO GROUP Sales Value Proportion by Product in 2024
 Table 94. ANHUI HUAMAO GROUP Sales Value Proportion by Application in 2024
 Table 95. ANHUI HUAMAO GROUP Sales Value Proportion by Geographic Area in 2024
 Table 96. ANHUI HUAMAO GROUP Medical Cotton Spunlaced Non-woven Fabric SWOT Analysis
 Table 97. ANHUI HUAMAO GROUP Recent Developments
 Table 98. Textisol Corporation Information
 Table 99. Textisol Description and Major Businesses
 Table 100. Textisol Product Models, Descriptions and Specifications
 Table 101. Textisol Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Textisol Recent Developments
 Table 103. Spuntech Corporation Information
 Table 104. Spuntech Description and Major Businesses
 Table 105. Spuntech Product Models, Descriptions and Specifications
 Table 106. Spuntech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Spuntech Recent Developments
 Table 108. Ihsan Sons Corporation Information
 Table 109. Ihsan Sons Description and Major Businesses
 Table 110. Ihsan Sons Product Models, Descriptions and Specifications
 Table 111. Ihsan Sons Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Ihsan Sons Recent Developments
 Table 113. Welspun Corporation Information
 Table 114. Welspun Description and Major Businesses
 Table 115. Welspun Product Models, Descriptions and Specifications
 Table 116. Welspun Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. Welspun Recent Developments
 Table 118. Fujian Funeng Corporation Information
 Table 119. Fujian Funeng Description and Major Businesses
 Table 120. Fujian Funeng Product Models, Descriptions and Specifications
 Table 121. Fujian Funeng Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. Fujian Funeng Recent Developments
 Table 123. XINLONG Corporation Information
 Table 124. XINLONG Description and Major Businesses
 Table 125. XINLONG Product Models, Descriptions and Specifications
 Table 126. XINLONG Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 127. XINLONG Recent Developments
 Table 128. Salvin Textile Corporation Information
 Table 129. Salvin Textile Description and Major Businesses
 Table 130. Salvin Textile Product Models, Descriptions and Specifications
 Table 131. Salvin Textile Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 132. Salvin Textile Recent Developments
 Table 133. JIAXIN MEDICAL Corporation Information
 Table 134. JIAXIN MEDICAL Description and Major Businesses
 Table 135. JIAXIN MEDICAL Product Models, Descriptions and Specifications
 Table 136. JIAXIN MEDICAL Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 137. JIAXIN MEDICAL Recent Developments
 Table 138. TEXHONG Corporation Information
 Table 139. TEXHONG Description and Major Businesses
 Table 140. TEXHONG Product Models, Descriptions and Specifications
 Table 141. TEXHONG Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 142. TEXHONG Recent Developments
 Table 143. Sanitars Corporation Information
 Table 144. Sanitars Description and Major Businesses
 Table 145. Sanitars Product Models, Descriptions and Specifications
 Table 146. Sanitars Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 147. Sanitars Recent Developments
 Table 148. Eruslu Nonwoven Group (ENG) Corporation Information
 Table 149. Eruslu Nonwoven Group (ENG) Description and Major Businesses
 Table 150. Eruslu Nonwoven Group (ENG) Product Models, Descriptions and Specifications
 Table 151. Eruslu Nonwoven Group (ENG) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 152. Eruslu Nonwoven Group (ENG) Recent Developments
 Table 153. Orma Spunlace Corporation Information
 Table 154. Orma Spunlace Description and Major Businesses
 Table 155. Orma Spunlace Product Models, Descriptions and Specifications
 Table 156. Orma Spunlace Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 157. Orma Spunlace Recent Developments
 Table 158. Rusvata Corporation Information
 Table 159. Rusvata Description and Major Businesses
 Table 160. Rusvata Product Models, Descriptions and Specifications
 Table 161. Rusvata Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 162. Rusvata Recent Developments
 Table 163. MOGUL Corporation Information
 Table 164. MOGUL Description and Major Businesses
 Table 165. MOGUL Product Models, Descriptions and Specifications
 Table 166. MOGUL Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 167. MOGUL Recent Developments
 Table 168. Napal Corporation Information
 Table 169. Napal Description and Major Businesses
 Table 170. Napal Product Models, Descriptions and Specifications
 Table 171. Napal Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 172. Napal Recent Developments
 Table 173. WPT Nonwovens Corporation Information
 Table 174. WPT Nonwovens Description and Major Businesses
 Table 175. WPT Nonwovens Product Models, Descriptions and Specifications
 Table 176. WPT Nonwovens Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 177. WPT Nonwovens Recent Developments
 Table 178. Taebong Corporation Information
 Table 179. Taebong Description and Major Businesses
 Table 180. Taebong Product Models, Descriptions and Specifications
 Table 181. Taebong Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 182. Taebong Recent Developments
 Table 183. Daesung Medical Corporation Information
 Table 184. Daesung Medical Description and Major Businesses
 Table 185. Daesung Medical Product Models, Descriptions and Specifications
 Table 186. Daesung Medical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 187. Daesung Medical Recent Developments
 Table 188. Key Raw Materials Distribution
 Table 189. Raw Materials Key Suppliers
 Table 190. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 191. Milestones in Production Technology Evolution
 Table 192. Distributors List
 Table 193. Market Trends and Market Evolution
 Table 194. Market Drivers and Opportunities
 Table 195. Market Challenges, Risks, and Restraints
 Table 196. Research Programs/Design for This Report
 Table 197. Key Data Information from Secondary Sources
 Table 198. Key Data Information from Primary Sources


List of Figures
 Figure 1. Medical Cotton Spunlaced Non-woven Fabric Product Picture
 Figure 2. Global Medical Cotton Spunlaced Non-woven Fabric Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Below 40gsm Product Picture
 Figure 4. 40-70gsm Product Picture
 Figure 5. 70gsm and Above Product Picture
 Figure 6. Global Medical Cotton Spunlaced Non-woven Fabric Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Surgical Gown
 Figure 8. Protective Suit
 Figure 9. Medical Masks
 Figure 10. Medical Gauze
 Figure 11. Others
 Figure 12. Medical Cotton Spunlaced Non-woven Fabric Report Years Considered
 Figure 13. Global Medical Cotton Spunlaced Non-woven Fabric Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Medical Cotton Spunlaced Non-woven Fabric Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Medical Cotton Spunlaced Non-woven Fabric Revenue Market Share by Region (2020-2031)
 Figure 17. Global Medical Cotton Spunlaced Non-woven Fabric Sales (2020-2031) & (Tons)
 Figure 18. Global Medical Cotton Spunlaced Non-woven Fabric Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 19. Global Medical Cotton Spunlaced Non-woven Fabric Sales Market Share by Region (2020-2031)
 Figure 20. Global Medical Cotton Spunlaced Non-woven Fabric Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 21. Global Medical Cotton Spunlaced Non-woven Fabric Production Trend by Region (2020-2031) (Tons)
 Figure 22. Global Medical Cotton Spunlaced Non-woven Fabric Production Market Share by Region (2020-2031)
 Figure 23. Production Capacity Enablers & Constraints
 Figure 24. Medical Cotton Spunlaced Non-woven Fabric Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 25. Medical Cotton Spunlaced Non-woven Fabric Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 26. Medical Cotton Spunlaced Non-woven Fabric Production Growth Rate in China (2020-2031) & (Tons)
 Figure 27. Medical Cotton Spunlaced Non-woven Fabric Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 28. Top 5 and Top 10 Manufacturers Medical Cotton Spunlaced Non-woven Fabric Sales Volume Market Share in 2024
 Figure 29. Global Medical Cotton Spunlaced Non-woven Fabric Revenue Market Share Ranking (2024)
 Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 31. Below 40gsm Revenue Market Share by Manufacturer in 2024
 Figure 32. 40-70gsm Revenue Market Share by Manufacturer in 2024
 Figure 33. 70gsm and Above Revenue Market Share by Manufacturer in 2024
 Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 36. Global Medical Cotton Spunlaced Non-woven Fabric Sales Market Share by Type (2020-2031)
 Figure 37. Global Medical Cotton Spunlaced Non-woven Fabric Revenue Market Share by Type (2020-2031)
 Figure 38. Global Medical Cotton Spunlaced Non-woven Fabric Sales Market Share by Application (2020-2031)
 Figure 39. Global Medical Cotton Spunlaced Non-woven Fabric Revenue Market Share by Application (2020-2031)
 Figure 40. North America Medical Cotton Spunlaced Non-woven Fabric Sales YoY (2020-2031) & (Tons)
 Figure 41. North America Medical Cotton Spunlaced Non-woven Fabric Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. North America Top 5 Manufacturers Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) in 2024
 Figure 43. North America Medical Cotton Spunlaced Non-woven Fabric Sales Volume (Tons) by Type (2020- 2031)
 Figure 44. North America Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 45. North America Medical Cotton Spunlaced Non-woven Fabric Sales Volume (Tons) by Application (2020-2031)
 Figure 46. North America Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. US Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 48. Canada Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 49. Mexico Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 50. Europe Medical Cotton Spunlaced Non-woven Fabric Sales YoY (2020-2031) & (Tons)
 Figure 51. Europe Medical Cotton Spunlaced Non-woven Fabric Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Europe Top 5 Manufacturers Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) in 2024
 Figure 53. Europe Medical Cotton Spunlaced Non-woven Fabric Sales Volume (Tons) by Type (2020-2031)
 Figure 54. Europe Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Europe Medical Cotton Spunlaced Non-woven Fabric Sales Volume (Tons) by Application (2020-2031)
 Figure 56. Europe Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Germany Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 58. France Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 59. U.K. Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 60. Italy Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 61. Russia Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 62. Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Sales YoY (2020-2031) & (Tons)
 Figure 63. Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Asia-Pacific Top 8 Manufacturers Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) in 2024
 Figure 65. Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Sales Volume (Tons) by Type (2020- 2031)
 Figure 66. Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 67. Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Sales Volume (Tons) by Application (2020-2031)
 Figure 68. Asia-Pacific Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Indonesia Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 70. Japan Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 71. South Korea Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 72. China Taiwan Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 73. India Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2031) & (US$ Million)
 Figure 74. Central and South America Medical Cotton Spunlaced Non-woven Fabric Sales YoY (2020-2031) & (Tons)
 Figure 75. Central and South America Medical Cotton Spunlaced Non-woven Fabric Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Central and South America Top 5 Manufacturers Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) in 2024
 Figure 77. Central and South America Medical Cotton Spunlaced Non-woven Fabric Sales Volume (Tons) by Type (2021-2031)
 Figure 78. Central and South America Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Central and South America Medical Cotton Spunlaced Non-woven Fabric Sales Volume (Tons) by Application (2020-2031)
 Figure 80. Central and South America Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. Brazil Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2025) & (US$ Million)
 Figure 82. Argentina Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2025) & (US$ Million)
 Figure 83. Middle East, and Africa Medical Cotton Spunlaced Non-woven Fabric Sales YoY (2020-2031) & (Tons)
 Figure 84. Middle East and Africa Medical Cotton Spunlaced Non-woven Fabric Revenue YoY (2020-2031) & (US$ Million)
 Figure 85. Middle East and Africa Top 5 Manufacturers Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) in 2024
 Figure 86. Middle East and Africa Medical Cotton Spunlaced Non-woven Fabric Sales Volume (Tons) by Type (2021-2031)
 Figure 87. South America Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 88. Middle East and Africa Medical Cotton Spunlaced Non-woven Fabric Sales Volume (Tons) by Application (2020-2031)
 Figure 89. Middle East and Africa Medical Cotton Spunlaced Non-woven Fabric Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 90. GCC Countries Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2025) & (US$ Million)
 Figure 91. Turkey Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2025) & (US$ Million)
 Figure 92. Egypt Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2025) & (US$ Million)
 Figure 93. South Africa Medical Cotton Spunlaced Non-woven Fabric Revenue (2020-2025) & (US$ Million)
 Figure 94. Medical Cotton Spunlaced Non-woven Fabric Industry Chain Mapping
 Figure 95. Regional Medical Cotton Spunlaced Non-woven Fabric Manufacturing Base Distribution (%)
 Figure 96. Medical Cotton Spunlaced Non-woven Fabric Production Process
 Figure 97. Regional Medical Cotton Spunlaced Non-woven Fabric Production Cost Structure
 Figure 98. Channels of Distribution (Direct Vs Distribution)
 Figure 99. Bottom-up and Top-down Approaches for This Report
 Figure 100. Data Triangulation
 Figure 101. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Acupuncture Non-Woven Fabric Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29M3103
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Non-Woven Needle Felts Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33R20002
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Textile Electrode Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0S20510
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Textile and Fabric Restoration and Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11O20210
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions